Answer
It is unknown whether fidaxomicin or its metabolites pass into human breast milk, and although effects on breastfed infants are not anticipated because systemic exposure is low, a risk cannot be excluded.
Sources for this answer
- Fidaxomicin 200mg film-coated tabletsTillotts Pharma UK Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 3Document updated
Sources checked